Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H L Mathews

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Journal of Immunological Methods|January 1, 1979
Purification of antibodies to bacterial antigens by an immunoadsorbent and a method to quantify their reaction with insoluble bacterial targetsH L Mathews, P Minden
Cancer Research|September 1, 1980
Suppression and immunotherapy of the guinea pig line 10 hepatocarcinoma mediated by heat-killed disrupted Mycobacterium bovis strain Bacillus Calmette-GuérinP Minden, H L Mathews
Infection and Immunity|March 1, 1992
Growth inhibition of Candida albicans by interleukin-2-activated splenocytesD W Beno, H L Mathews
Journal of Immunological Methods|September 27, 1993
A quantitative radiometric assay to measure mammalian cell binding to hyphae of Candida albicansC B Forsyth, H L Mathews
Cellular Immunology|May 25, 1996
Lymphocytes utilize CD11b/CD18 for adhesion to Candida albicansC B Forsyth, H L Mathews
Cellular Immunology|June 1, 1990
Growth inhibition of Candida albicans by interleukin-2-induced lymph node cellsD W Beno, H L Mathews
The Ohio Dental Journal|May 1, 1985
Does joining a preferred provider plan bring new dental patients?H L Mathews, R E Burnkrant
Pediatric Research|February 18, 1999
Differential effects of glucocorticoids on colony stimulating factors produced by neonatal mononuclear cellsL Witek-Janusek, H L Mathews
Biotherapy (Dordrecht, Netherlands)|January 1, 1992
Systemic IL-1 and adjuvant treatment of an experimental tumor. II. Immune status during primary tumor challengeS M Kiertscher, H L Mathews
Journal of Medical Microbiology|November 20, 1998
Antifungal activity of interleukin-2-activated natural killer (NK1.1+) lymphocytes against Candida albicansH L Mathews, L Witek-Janusek
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Journal of Immunological Methods|January 1, 1979
Purification of antibodies to bacterial antigens by an immunoadsorbent and a method to quantify their reaction with insoluble bacterial targetsH L Mathews, P Minden
Cancer Research|September 1, 1980
Suppression and immunotherapy of the guinea pig line 10 hepatocarcinoma mediated by heat-killed disrupted Mycobacterium bovis strain Bacillus Calmette-GuérinP Minden, H L Mathews
Infection and Immunity|March 1, 1992
Growth inhibition of Candida albicans by interleukin-2-activated splenocytesD W Beno, H L Mathews
Journal of Immunological Methods|September 27, 1993
A quantitative radiometric assay to measure mammalian cell binding to hyphae of Candida albicansC B Forsyth, H L Mathews
Cellular Immunology|May 25, 1996
Lymphocytes utilize CD11b/CD18 for adhesion to Candida albicansC B Forsyth, H L Mathews
Cellular Immunology|June 1, 1990
Growth inhibition of Candida albicans by interleukin-2-induced lymph node cellsD W Beno, H L Mathews
The Ohio Dental Journal|May 1, 1985
Does joining a preferred provider plan bring new dental patients?H L Mathews, R E Burnkrant
Pediatric Research|February 18, 1999
Differential effects of glucocorticoids on colony stimulating factors produced by neonatal mononuclear cellsL Witek-Janusek, H L Mathews
Biotherapy (Dordrecht, Netherlands)|January 1, 1992
Systemic IL-1 and adjuvant treatment of an experimental tumor. II. Immune status during primary tumor challengeS M Kiertscher, H L Mathews
Journal of Medical Microbiology|November 20, 1998
Antifungal activity of interleukin-2-activated natural killer (NK1.1+) lymphocytes against Candida albicansH L Mathews, L Witek-Janusek
Pageof 5